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Methods: We retrospectively analyzed data from patients with massive and submassive
PE treated with USAT over a 2-year period. EKOS catheters (EkoSonic Endovascular
system, EKOS Corp., Bothell, WA) were placed in the largest lower lobe pulmonary
artery, bilaterally in 14 patients (93%) and unilaterally in 1 patient (7%). Recombinant
t-PA was administered through the EKOS catheters as a 5 mg bolus followed by 1
mg/hour for a maximum dose of 20 mg.
Results: Fifteen patients received USAT for PE between May, 2010 and April, 2012. Ten
patients (67%) presented with saddle emboli. Four patients (27%) presented with massive
PE requiring inotropic support and mechanical ventilation. Technical success in EKOS
catheter placement was 100%. Pre-USAT echocardiographic RV/LV diameter ratios were
obtained in 13 (87%) patients and were abnormal in 12 (92%) patients (mean 1.23 
0.28). After USAT, 5(33%) patients had follow-up echocardiograms, in which the RV/LV
ratio normalized in all patients (mean 0.83  0.06) (p0.07). Mean pulmonary artery
(PA) pressures were 39.9  2.1 before treatment and 31.2  3.2 after treatment (p  0.03).
Three patients (20%) had follow-up angiography, of which 2 (67%) had complete
resolution of emboli. Mean hospital stay was 10.88.59 days. Thirteen patients
(87%) were discharged alive. One patient (7%) required a blood transfusion.
Conclusions: In patients with massive and submassive PE, USAT restores hemodynamic
stability and reverses right ventricular dilatation and with minimal risk of bleeding
complications.
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Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic
Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum
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12nd Medical School, Charles University, University Hospital Motol, Prague 5,
Czech Republic
Background: The aim of this study was to determine whether the differences in the baseline
septal morphology influenced outcomes of patients after alcohol septal ablation (ASA).
Methods: A total of 100 consecutive, highly symptomatic patients with HOCM and a neutral
or sigmoid septum (74 patients vs 26 patients) underwent ASA and were examined clinically
and echocardiographically at baseline and at follow-up (median 30 months vs 24 months).
Results: At baseline, a neutral septum morphology was associated with a thicker basal
septum [21 (19-24) mm vs 19 (18-20) mm; p0.01] and higher pressure gradient at rest [59
(39-80) mm vs 43 (33-50) mm; p0.01], but a similar pressure gradient after provocation [100
(72-120) mmHg vs 97 (70-110) mmHg; p0.31], and subsequently both resting gradient [10
(10-16) mmHg vs 12 (10-15) mmHg; p0.67] and provoked gradient after ASA [20 (10-30)
mmHg vs 18 (12-25) mmHg; p0.71]. Four patients died during follow-up (4% vs 1%; NS).
Pressure gradient, septum thickness and symptoms decreased significantly in both groups.
Conclusions: Patients treated with ASA who had a sigmoid septum were characterized
at baseline by a thinner basal septum and lower pressure gradient at rest. However, they
showed an identical pressure gradient after provocation and subsequently after ASA. ASA
was safe and effective in both groups of patients.
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Background: Alcohol septal ablation (ASA) is a catheter-based intervention that has
been used as an alternative to surgical myectomy in highly symptomatic patients with
hypertrophic obstructive cardiomyopathy (HOCM). However, clinically relevant compli-
cations can result, including death and complete heart block (CHB) associated with
syncope or resuscitation.This study was designed to evaluate the incidence of major
complications with a focus on CHB after ASA for HOCM.
Methods: This international, multicenter, retrospective study reviewed 545 patients who
were treated using ASA; 421 (77%) met the inclusion criteria for this study. Clinical and
echocardiographic follow-up (3–6 months) was completed in 394 patients (94%).
Results: ASA led to a significant reduction in symptoms and outflow gradient. One
patient (0.2%) died of cardiac tamponade four days after ASA. Two other patients (0.5%)
died several weeks after ASA (sudden death of unknown cause). Sustained ventricular
arrhythmias occurred within hospital stay in three patients (0.7%). A total of 70 patients
(17%) developed mostly transient intra/post-procedural CHB; in 30% of them, CHB
occurred/reoccurred later than 24 hours after ASA. Ninety-seven percent of CHB
occurred until the fifth post-ASA day. Permanent pacemakers for CHB were implanted in
35 patients (8%). Multivariate analysis identified the intra-procedural bundle branch block
and age as independent predictors of CHB.
Conclusions: In this multicenter study, ASA was clinically effective in highly symp-
tomatic patients undergoing a first intervention for HOCM. The most frequent major
post-procedural complication was CHB (17%) that occurred late or recurred in almost
one-third of these cases (5%). Ninety-seven percent of all CHB cases occurred until the
fifth post-procedural day. Independent predictors of its development were intra-procedural
bundle branch block and age of patients. Difficulties in predicting CHB should lead to
close post-procedural monitoring and hospital stays lasting at least 5 days. Generally,
these results highlight the importance of proper interventional training and establishing
complex “HCM centers” as a prerequisite for all institutions offering ASA.
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Impact of left atrial appendage occlusion, with percutaneous device on left
atrial function
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Background: Favorable results with the occlusion of the left atrial appendage (LAA),
using percutaneous devices, for thromboembolic events prevention, has lead to a
widespread use of this technique. However, the long-term effects on left atrial (LA)
function are unclear. The objective of this study was to evaluate the impact of LAA
occlusion on LA function.
Methods: LAA occlusion by percutaneous femoral access was performed in five female
common swine, in sinus rhythm. TEE evaluation of LA dimensions using 2D, mitral and
pulmonary veins (PV) Doppler flow, and TDI of mitral annular motion was performed at
baseline and after 90 days.
Results: Four animals survived until the 90 days. Weight and body surface area increased
from 53.04.7Kg/1.30.1m2 to 74.11.5Kg/1.60.4m2. At basaline, minimum LA
diameter, area and volume were 22.02.1 mm/m2; 5.60.4cm2/m2 and 12.11.1cm3/
m2. Maximum LA diameter, area and volume were 27.63.7mm/m2;7.81.0cm2/m2
and 19.14.0cm3/m2. At 90 days, systolic diameter, area and volume were
19.52.9mm/m2; 5.50.6cm2/m2 and 13.21.4cm3/m2 and diastolic values were
40.15.6mm/m2; 8.91.5cm2/m2 and 27.16.0cm3/m2. LA ejection fraction signifi-
cantly increased from 359% to 507% at 90 days (p0.038). There was a significant
increase in LA maximal diameter (p0.04) and a trend toward LA maximal volume
increase from baseline to follow-up (p0.082). There was a significant increase of E wave
VTI (p0.024) from 7.40.6cm to 10.51.4cm. TDI of mitral annulus showed E‘, A‘
and S‘ basal velocities of 10.82.7cm/s; 8.42.4cm/s and 8.41.6cm/s with no
significant changes to follow-up. The E/E‘ ratio suffered no significant change, and there
was a trend towards peak A‘ wave velocity (p0.067). Baseline PV flow velocities were:
S 65.02.8cm/s; A 31.08.5cm/s and D 51.07.1cm/s. At 90 days, S, A and D, were
55.04.2cm/s; 21.53.5cm/s and 44.56.4cm/s. The S/D ratio was 1.30.1 at baseline
and 1.30.3 at 90 days. The D velocity at follow-up, revealed a significant reduction
relative to the baseline (p0.049).
Conclusions: This study provides initial evidence that LAA occlusion may not significantly
impair LA function and does not lead to armful atrial remodeling or loss of contractile function.
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Background: Left atrial appendage (LAA) occlusion is proposed to reduce the risk of
thromboembolic stroke in atrial fibrillation patients.
Methods: WaveCrestTM (Coherex Medical, Salt Lake City, UT) LAA occluder was
deployed in 6 dogs via transseptal puncture under fluoroscopy and transesophageal
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